149 related articles for article (PubMed ID: 7407085)
1. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.
Janatova J; Lorenz PE; Schechter AN; Prahl JW; Tack BF
Biochemistry; 1980 Sep; 19(19):4471-8. PubMed ID: 7407085
[TBL] [Abstract][Full Text] [Related]
2. The effects of iodine and thiol-blocking reagents on complement component C2 and on the assembly of the classical-pathway C3 convertase.
Kerr MA; Parkes C
Biochem J; 1984 Apr; 219(2):391-9. PubMed ID: 6611150
[TBL] [Abstract][Full Text] [Related]
3. Reduction of the beta-Cys-gamma-Glu thiol ester bond of human C3 with sodium borohydride.
Thomas ML; Davidson FF; Tack BF
J Biol Chem; 1983 Nov; 258(22):13580-6. PubMed ID: 6139373
[TBL] [Abstract][Full Text] [Related]
4. Evidence for presence of an internal thiolester bond in third component of human complement.
Tack BF; Harrison RA; Janatova J; Thomas ML; Prahl JW
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5764-8. PubMed ID: 6934510
[TBL] [Abstract][Full Text] [Related]
5. Sulfhydryl chemistry of Salmonella typhimurium phosphoribosylpyrophosphate synthetase: identification of two classes of cysteinyl residues.
Harlow KW; Switzer RL
Arch Biochem Biophys; 1990 Feb; 276(2):466-72. PubMed ID: 2154950
[TBL] [Abstract][Full Text] [Related]
6. Third component of complement (C3): structural properties in relation to functions.
Bokisch VA; Dierich MP; Mūller-Eberhard HJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
[TBL] [Abstract][Full Text] [Related]
7. Identification of the C3b receptor-binding domain in third component of complement.
Becherer JD; Lambris JD
J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
[TBL] [Abstract][Full Text] [Related]
8. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of a cytosolic phospholipase A2 by thiol-modifying reagents: cysteine residues as potential targets of phospholipase A2.
Li B; Copp L; Castelhano AL; Feng R; Stahl M; Yuan Z; Krantz A
Biochemistry; 1994 Jul; 33(28):8594-603. PubMed ID: 8031794
[TBL] [Abstract][Full Text] [Related]
10. Heat-induced thiol-disulfide interchange reaction on the third component of human complement, C3.
Seya T; Nagasawa S
J Biochem; 1988 May; 103(5):792-6. PubMed ID: 3182749
[TBL] [Abstract][Full Text] [Related]
11. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
Pangburn MK; Müller-Eberhard HJ
J Exp Med; 1980 Oct; 152(4):1102-14. PubMed ID: 6903192
[TBL] [Abstract][Full Text] [Related]
12. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
13. Location of the interchain disulfide bonds of the fourth component of human complement (C4): evidence based on the liberation of fragments secondary to thiol-disulfide interchange reactions.
Seya T; Nagasawa S; Atkinson JP
J Immunol; 1986 Jun; 136(11):4152-6. PubMed ID: 3701066
[TBL] [Abstract][Full Text] [Related]
14. Covalent binding and hemolytic activity of complement proteins.
Law SK; Lichtenberg NA; Levine RP
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the properdin-binding site in the third component of complement.
Lambris JD; Alsenz J; Schulz TF; Dierich MP
Biochem J; 1984 Jan; 217(1):323-6. PubMed ID: 6696726
[TBL] [Abstract][Full Text] [Related]
16. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
[TBL] [Abstract][Full Text] [Related]
17. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
Isenman DE; Kells DI; Cooper NR; Müller-Eberhard HJ; Pangburn MK
Biochemistry; 1981 Jul; 20(15):4458-67. PubMed ID: 7284336
[TBL] [Abstract][Full Text] [Related]
18. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
Janatova J
Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
[No Abstract] [Full Text] [Related]
19. Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase. Inhibition of factor I-mediated cleavage of C3b.
Ekdahl KN; Nilsson B
J Immunol; 1995 Jun; 154(12):6502-10. PubMed ID: 7539023
[TBL] [Abstract][Full Text] [Related]
20. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
